Seizing Opportunities in Japan the Second Largest Innovation Driven Pharmaceutical Market
October 22, 2018
Japan is and will remain the second largest market for branded pharmaceuticals and innovation. Continued investment in development and commercialization of pharmaceuticals in Japan is creating many opportunities and growing potential for multinational biopharma companies. This is driven in part by ongoing regulatory and government initiatives that reward innovation, shifts in population demographics, and increased disease awareness and identifiable patient populations, amongst other factors. In this webinar IQVIA Japan discusses how to seize these opportunities and the strong potential outlook in the market in the coming years.